Work

Engineered T cells for cancer therapy

Year: 2014

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-014-1568-1

Authors: Carl H. June, Marcela V. Maus, Gabriela Plesa, Laura A. Johnson, Yangbing Zhao, Bruce L. Levine, Stephan A. Grupp, David L. Porter

Institutions: Abramson Cancer Center, University of Pennsylvania, Children's Hospital of Philadelphia

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G1214792496, G1403651065, G208896463, CD19 Directed CAR Therapy, Designer antigen receptors to re-direct T cells to the NY-ESO-1 tumor antigen, Gene-engineered adoptive T cell immunotherapy of GBM

OpenAlex ID: W1972297696

FWCI: 7.328

Cites: 54

Cited by: 124

Related to: 10